PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, supplying promising improvements across different professional medical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA presents a safer, far more dependable choice for th